MedTrace Logo

Photobiomodulation Therapy in Persons With Multiple Sclerosis

NCT03691766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-02-26

No results posted yet for this study

Summary

This study will test whether photobiomodulation therapy improves muscle endurance and decreases inflammation in persons with relapsing-remitting multiple sclerosis. We will also investigate mechanisms for any improvements.

Conditions

  • Multiple Sclerosis, Relapsing-Remitting

Interventions

OTHER

Photobiomodulation Therapy

Photobiomodulation therapy, a mix of red lights thought to improve mitochondrial function will be applied in and acute and chronic manner to test whether muscle fatigue improves in persons with MS.

OTHER

Placebo

Device with sham light source

Sponsors & Collaborators

  • University of Wisconsin, Milwaukee

    collaborator OTHER

  • Marquette University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2019-09-23
Completion
2019-09-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03691766 on ClinicalTrials.gov